Trexquant Investment’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-172,520
Closed -$8.81M 1938
2024
Q4
$8.81M Buy
172,520
+30,167
+21% +$1.48M 0.1% 312
2024
Q3
$5.87M Buy
142,353
+70,842
+99% +$3.4M 0.07% 413
2024
Q2
$3.44M Buy
+71,511
New +$3.17M 0.05% 531
2024
Q1
Sell
-43,738
Closed -$2.84M 1845
2023
Q4
$2.84M Sell
43,738
-9,212
-17% -$555K 0.06% 441
2023
Q3
$3.46M Sell
52,950
-9,284
-15% -$584K 0.09% 328
2023
Q2
$3.62M Buy
+62,234
New +$3.93M 0.09% 295
2021
Q3
Sell
-5,296
Closed -$494K 1563
2021
Q2
$494K Sell
5,296
-4,282
-45% -$415K 0.04% 494
2021
Q1
$1.02M Buy
+9,578
New +$994K 0.09% 274

Other funds holding NARI

Trexquant Investment's NARI Position: Q1 2025 in Review

Trexquant Investment sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 172,520 shares — an estimated $8.81M sold.

Trexquant Investment first reported a position in NARI in Q1 2021 and held it in 8 quarters. The position peaked at $8.81M in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Trexquant Investment reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Trexquant Investment sold 172,520 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $8.81M.
  • Trexquant Investment first reported a position in Inari Medical, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • Trexquant Investment's Inari Medical, Inc. Common Stock position peaked at $8.81M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Trexquant Investment's 13F filing for Q1 2025, filed 14 May 2025.